Lv61
2050 积分 2024-01-12 加入
Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies
12天前
已完结
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)
12天前
已完结
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
15天前
已完结
Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up
22天前
已完结
Use of Therapeutic Drug Monitoring Does Not Add Clinical Value for Voclosporin in Patients with Lupus Nephritis
28天前
已关闭
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
1个月前
已完结
Trends and the Role of Gene-Environment Interactions in Idiopathic Membranous Nephropathy in Northern China
1个月前
已完结
Membranous nephropathy
1个月前
已完结
The efficacy and safety of GLP-1 agonists to modify cardiovascular morbidity in patients with obesity without diabetes mellitus: a meta-analysis involving 32,884 patients
1个月前
已完结
The role of efferent cholinergic transmission for the insulinotropic and glucagonostatic effects of GLP-1
1个月前
已完结
皖公网安备34019202002308
